Economic impact of the new oral treatments for multiple sclerosis.

@article{Ayuso2018EconomicIO,
  title={Economic impact of the new oral treatments for multiple sclerosis.},
  author={L {\'A}lvarez Ayuso and Bel{\'e}n Rodr{\'i}guez Marrod{\'a}n and M R Blasco Qu{\'i}lez and Juan Antonio Garc{\'i}a-Merino and Angel S{\'a}nchez Guerrero},
  journal={Neurologia},
  year={2018}
}
INTRODUCTION Multiple sclerosis (MS) is a chronic disease affecting the central nervous system and is characterised by inflammation, demyelination, gliosis, and axonal damage. The introduction of dimethyl fumarate and teriflunomide has led to an increase in the number of alternative first-line therapies for MS. The objective of this study was to evaluate… CONTINUE READING